Meds raised $16M from new and existing investors.

Sweden Investments 20 November 2019
Share on FacebookShare on Twitter

Meds, a Stockholm, Sweden-based compay operating an online pharmacy business, completed a SEK 150M ($15.6M) capital investment round.

The funding includes a SEK 42M ($4.3M) capital raise announced in September 2019, and was backed by new and existing investors, including Richard Båge, Måns Zelmerlöw, Martin Wattin and Michael Storåkers, in a deal that valued the company at SEK 270 million ($28M) pre money.

Meds, founded in 2017 and led by CEO Björn Thorngren, had sales of SEK 25 million last year and expects to get to SEK 100 million at the end of 2019.